Derma Sciences is a medical technology company with its focus on advanced wound care. The company currently targets three segments of the wound care marketplace: pharmaceutical wound care products; advanced wound care dressings addressing chronic wounds, including diabetic ulcers; and traditional dressings. Based on excellent Phase 2 data, the company has commenced Phase 3 clinical trials in diabetic foot ulcer healing with DSC127. Other novel products include the company’s MEDIHONEY product, TCC-EZ, XTRASORB and BIOGUARD. For more information, visit the company’s Web site: http://www.dermasciences.com
Let us hear your thoughts below: